000 | 01119 a2200289 4500 | ||
---|---|---|---|
005 | 20250514053250.0 | ||
264 | 0 | _c20030326 | |
008 | 200303s 0 0 eng d | ||
022 | _a1472-4472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeopold, Claudia S | |
245 | 0 | 0 |
_aPVAC (Corixa/Genesis/Medicis). _h[electronic resource] |
260 |
_bCurrent opinion in investigational drugs (London, England : 2000) _cNov 2002 |
||
300 |
_a1604-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBacterial Vaccines _xpharmacology |
650 | 0 | 4 |
_aClinical Trials, Phase I as Topic _xstatistics & numerical data |
650 | 0 | 4 |
_aClinical Trials, Phase II as Topic _xstatistics & numerical data |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMycobacterium _ximmunology |
650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xlegislation & jurisprudence |
700 | 1 | _aMaibach, Howard I | |
773 | 0 |
_tCurrent opinion in investigational drugs (London, England : 2000) _gvol. 3 _gno. 11 _gp. 1604-7 |
|
999 |
_c12281710 _d12281710 |